There is no dispute with what you say. However Big Pharma as purchaser is free to pursue autism with NNZ-2591 should it decide. 1% of the US populace has autism. That is a market of 3.33 million people. Assume 30% uptake over time at $10k a year and revenues are at $10 billion per annum. Shazam!
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-11176
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.94 |
Change
0.000(0.00%) |
Mkt cap ! $2.037B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 660 | $16.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.62 | 144 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 660 | 16.750 |
12 | 4424 | 16.730 |
3 | 2942 | 16.720 |
1 | 870 | 16.700 |
3 | 1629 | 16.680 |
Price($) | Vol. | No. |
---|---|---|
14.620 | 144 | 1 |
15.160 | 2571 | 3 |
15.390 | 5 | 1 |
15.420 | 27 | 2 |
15.430 | 33 | 1 |
Last trade - 09.58am 14/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online